GGrantIndex
Sort

50,496 grants matching lung cancer

The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)

$873,129
Gregory D Kirk · Johns Hopkins University · R01 · FY2010 · HL

Molecular prediction of myeloma in African Americans

$872,957
Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2025 · CA

Molecular Imaging of Primary Amyloid Cardiomyopathy

$872,796
Sharmila Dorbala · Brigham And Women'S Hospital · R01 · FY2016 · HL

Radiation-induced translational control of gene expression

$872,517
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

HARVARD COLLABORATIVE ORAL CANCER STUDY

$872,347
Harvard University (Sch Of Public Hlth) · R01 · FY2003 · CA

Cellular plasticity gives rise to phenotypic equilibrium in small cell lung carcinoma

$872,275
Mohamed E. Abazeed · Northwestern University At Chicago · U01 · FY2025 · CA

PULMONARY REHABILITATION IN ADVANCED LUNG CANCER SURVIVORS

$872,237
Case Western Reserve University · · FY2025 · Defense Health Agency

Project 1: Smoking, environmental and genomic factors in lung cancer and managing risk

$872,066
Christopher I. Amos · Baylor College Of Medicine · U19 · FY2023 · CA

Studying factors controlling cancer progression and immune recognition in mouse models

$871,800
Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA

Organ specific microenvironmental regulation of metastasis

$871,771
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Health Effects Of Exposures In Agriculture

$871,724
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Center for Interventional Oncology

$871,672
Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2020 · CA

Computational and Experimental RNA Nanobiology

$871,639
Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Resorbable Inferior Vena Cava Filter

$871,635
Mitchell Eggers · Adient Medical, Inc. · R44 · FY2015 · HL

Modulation of Viral Antigen Presentation in the Lung

$870,979
Anna Karolina Palucka · Jackson Laboratory · U19 · FY2023 · AI

Therapeutic targets and novel anticancer agents for endocrine cancers

$870,926
Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)

$870,850
Samuel E. Adunyah · Meharry Medical College · U54 · FY2015 · CA

Clinical Development of First-in-Class Therapy for Metastatic Breast Cancer

$870,684
Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2023 · CA

Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer

$870,416
Mark C Roser · Results Group · R44 · FY2021 · NR

Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies

$870,353
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Investigation of lung tumor development and treatment

$870,330
Tyler E Jacks · Massachusetts Institute Of Technology · U01 · FY2008 · CA

Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells

$869,665
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Imaging of Hematologic and Oncologic Disorders

$869,301
Brian D. Ross · University Of Michigan At Ann Arbor · R35 · FY2017 · CA

CCR-Frederick Flow Cytometry Core

$869,063
Kathleen Noer · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$868,844
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2019 · CA